- Home
- Publications
- Publication Search
- Publication Details
Title
Role of warfarin pharmacogenetic testing in clinical practice
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 11, Issue 3, Pages 439-448
Publisher
Future Medicine Ltd
Online
2010-04-19
DOI
10.2217/pgs.10.8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
- (2013) Mark H. Eckman ANNALS OF INTERNAL MEDICINE
- Potential Clinical and Economic Outcomes of CYP2C9 and VKORC1 Genotype-Guided Dosing in Patients Starting Warfarin Therapy
- (2009) J H S You et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population
- (2009) Paola Borgiani et al. PHARMACOGENOMICS
- CYP2C9*8is prevalent among African–Americans: implications for pharmacogenetic dosing
- (2009) Stuart A Scott et al. PHARMACOGENOMICS
- Genetic and clinical factors relating to warfarin dosing
- (2009) Daniel E. Jonas et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- CYP4F2 genetic variant alters required warfarin dose
- (2008) M. D. Caldwell et al. BLOOD
- The largest prospective warfarin-treated cohort supports genetic forecasting
- (2008) M. Wadelius et al. BLOOD
- Oral anticoagulants: Pharmacogenetics
- (2008) Giovanna D’Andrea et al. BLOOD REVIEWS
- Executive Summary
- (2008) Jack Hirsh et al. CHEST
- Pharmacology and Management of the Vitamin K Antagonists
- (2008) Jack Ansell et al. CHEST
- Influence of CYP2C9 genotype on warfarin dose requirements—a systematic review and meta-analysis
- (2008) Jonatan D. Lindh et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic Determinants of Response to Warfarin during Initial Anticoagulation
- (2008) Ute I. Schwarz et al. NEW ENGLAND JOURNAL OF MEDICINE
- VKORC1polymorphisms, haplotypes and haplotype groups on warfarin dose among African–Americans and European–Americans
- (2008) Nita A Limdi et al. PHARMACOGENOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now